Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Biotechnology > Strategic Analysis of the U.S. Biopharmaceuticals Market
Category
Biotechnology (1536)
Antibody & Immunity (193)
Biomarker (169)
Biomaterials (56)
Biotechnology Equipment (359)
Gene Therapeutics & RNAi (115)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

Strategic Analysis of the U.S. Biopharmaceuticals Market

Published by Frost & Sullivan
Published December, 2008 Product code 78024
Content info 128 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Strategic Analysis of the U.S. Biopharmaceuticals Market published by Frost & Sullivan in December, 2008. This report consists of 128 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service covers the strategic analysis of the U.S. biopharmaceutical market 2004-2014. Included are technology trends, total market revenue forecasts, and selected market segment revenue forecasts. The market is segmented by product class: antisense, cytokines and proteins, enzymes and hormones, gene and cell therapies, and vaccines. Major market challenges, drivers, and restraints and identified and discussed. Also included is selected late stage pipeline analysis.

Table of Contents

Table Of Contents

1. EXECUTIVE SUMMARY

  • Executive Summary
    • 1. Introduction

2. MARKET OVERVIEW

  • Research Scope and Methodology
    • 1. Scope and Segmentation
    • 2. Research Methodology
  • Market Introduction
    • 1. Measurements
    • 2. Introduction
    • 3. Main Classes of Biopharmaceuticals
    • 4. Recent Product Approvals
    • 5. Competitive Structure
  • Market Trends
    • 1. Hot Topics and Trends
    • 2. Industry Challenges
    • 3. Market Drivers
    • 4. Market Restraints
  • Pipeline Analysis
    • 1. Introduction
    • 2. Antisense Therapies
    • 3. Gene and Cell Therapies
    • 4. Hormones and Proteins
    • 5. Interferons and Interleukins
    • 6. Monoclonal Antibodies
    • 7. Vaccines
    • 8. Others

3. REVENUE ANALYSIS

  • Total Market Forecasts
    • 1. Revenue Forecasts
  • Select Sub Market Forecasts
    • 1. Introduction
    • 2. Monoclonal Antibodies Market Forecasts
    • 3. Human Growth Hormone Market Forecasts

4. DECISION SUPPORT DATABASES

  • Oncology Databases
    • 1. Cancer Cases
    • 2. Incidence of Breast Cancer
    • 3. Incidence of Colon and Rectum Cancer
    • 4. Incidence of Bladder Cancer
    • 5. Incidence of Lung Cancer
    • 6. Incidence of Stomach Cancer
  • Autoimmune and Inflammatory Disorders Databases
    • 1. Prevalence of Arthritis
    • 2. Prevalence of Psoriasis
    • 3. Prevalence of Multiple Sclerosis
  • Organ Transplants Databases
    • 1. The Total Number of Kidney Transplants
    • 2. Total Number of Heart Transplants
    • 3. Total Number of Liver Transplants
  • Cardiovascular Disorders
    • 1. Prevalence of Cardiovascular Diseases
    • 2. Prevalence of Coronary Heart Disease
    • 3. New Cases of Heart Attack
  • Neurodegenerative Disorders Databases
    • 1. Prevalence of Parkinson' s Disease
    • 2. Prevalence of Alzheimer' s Disease
    • 3. Prevalence of Epilepsy
    • 4. Incidence of Stroke
  • Respiratory Disorders Databases
    • 1. Prevalence of Asthma
    • 2. Prevalence of COPD
  • Miscellaneous Databases
    • 1. Age-Related Macular Degeneration Prevalence
    • 2. Incidence of Diabetes
Back to Top